参考文献/References:
[1] GINTER E,SIMKO V,WEINREBOVA D,LADECKA Z.Novel potential for the management of Alzheimer disease[J].Bratisl Lek Listy,2015,116(10):580-581.
[2] The Lancet Neurology.Alzheimer’s disease:a time for cautious optimism [J].Lancet Neurol,2015,14(8):779.
[3] ALBRAHIM T.The potential role of nutritional components in improving brain function among patients with Alzheimers disease:a meta-analysis of RCT studies [J].Neurosciences (Riyadh),2020,25(1):4-17.
[4] PABLO P D,MONLLOR B,MONCHO V,DOLORES D F.Visual function alterations in Alzheimer disease:A case report [J].Can J Ophthalmol,2016,51(1):e16-18.
[5] POLO V,RODRIGO M J,GARCIA-MARTIN E,OTIN S,LARROSA J M,FUERTES M I,et al.Visual dysfunction and its correlation with retinal changes in patients with Alzheimer’s disease [J].Eye (Lond),2017,31(7):1034-1041.
[6] BAMBO M P,GARCIA-MARTIN E,GUTIERREZ-RUIZ F,PINILLA J,PEREZ-OLIVAN S,LARROSA J M,et al.Analysis of optic disk color changes in Alzheimer’s disease:a potential new biomarker [J].Clin Neurol Neurosurg,2015,132:68-73.
[7] OH J,BAIK D J,AHN J.Inter-relationship between retinal and choroidal vasculatures using optical coherence tomography angiography in normal eyes [J].Eur J Ophthalmol,2020,30(1):48-57.
[8] SNYDER H M,KIM H,BAIN L J,EGGE R,CARRILLO M C.Alzheimer’s disease public-private partnerships:update 2014 [J] .Alzheimers Dement,2014,10(6):873-880.
[9] BERISHA F,FEKE G T,TREMPE C L,MCMEEL J W,SCHEPENS C L.Retinal abnormalities in early Alzheimer’s disease [J].Invest Ophthalmol Visual Sci,2007,48(5):2285-2289.
[10] VEVERKA K K,ABOUCHEHADE J E,IEZZI R,PULIDO J S.Noninvasive Grading of Radiation Retinopathy:The use of optical coherence tomography angiography [J].Retina,2015,35(11):2400-2410.
[11] ERSKINE L,HERRERA E.Connecting the retina to the brain [J].ASN Neuro,2014,6(6):pii1759091414562107.
[12] SEIL Y,ARC,NCESU T K,GRGR N,BECKMANN Y,ERTEKIN C.Dysphagia in Alzheimer’s disease [J].Neurophysiol Clin,2016,46(3):171-178.
[13] DELRIEU J,OUSSET P J,VOISIN T,VELLAS B.Amyloid beta peptide immunotherapy in Alzheimer disease [J].Rev Neurol,2014,170(12):739-748.
[14] YAVARPOUR-BALI H,GHASEMI-KASMAN M,SHOJAEI A.Direct reprogramming of terminally differentiated cells into neurons:A novel and promising strategy for Alzheimer’s disease treatment [J].Prog Neuropsychopharmacol Biol Psychiat,2020,98:109820.
[15] BIGOT C,VANHOUTTE G,VERHOYE M,LINDEN A V D.Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer’s disease transgenic mice [J].Neuroimage,2014,87:111-119.
[16] AGUZZI A.Neurodegeneration:Alzheimer’s disease under strain [J].Nature,2014,512(7512):32-34.
[17] KLOOS M,WEIGEL S,LUKSCH H.Anatomy and physiology of neurons in layer 9 of the chicken optic tectum [J].Front Neural Circuits,2019,13:63.
[18] MURCIA-BELMONTE V,ERSKINE L.Wiring the binocular visual pathways[J].Int J Mol Sci,2019,20(13): pii:E3282.
[19] SALAZAR-GONZALEZ A,KABA D,LI Y,LIU X.Segmentation of the blood vessels and optic disk in retinal images[J].IEEE J Biomed Health Inform,2014,18(6):1874-1886.
[20] JINDAL V.Interconnection between brain and retinal neurodegenerations [J].Mol Neurobiol,2015,51(3):885-892.
[21] JUNG N Y,HAN J C,ONG Y T,CHEUNG C Y,CHEN C P,WONG T Y,et al.Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer’s disease [J].J Neurol Sci,2019,396:94-101.
[22] MULDER J,ZILBERTER M,PASQUAR S J,ALPR A,SCHULTE G,FERREIRA S G,et al.Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease [J].Brain,2011,134:1041-1060.
[23] MASUZZO A,DINET V,CAVANAGH C,MASCARELLI F,KRANTIC S.Amyloidosis in retinal neurodegenerative diseases[J].Front Neurol,2016,7:127.
[24] VAN H J,WESSELING P,Van DEN HEUVEL L P,De WAAL R M,VERBEEK M M.Heparan sulphate proteoglycans in Alzheimer’s disease and amyloid-related disorders[J].Lancet Neurol,2003,2(8):482-492.
[25] MANUELIDIS L.Infectious particles,stress,and induced prion amyloids:a unifying perspective [J].Virulence,2013,4(5):373-383.
[26] BULUT M,KURTULU F,GZKAYA O,EROL M K,CENGIZ A,AKIDAN M,et al.Evaluation of optical coherence tomography angiographic findings in Alzheimer’s type dementia [J].Br J Ophthalmol,2018,102(2):233-237.
相似文献/References:
[1]刘章 周琼.阿尔茨海默病、视神经及特殊蛋白三者关系的研究进展[J].眼科新进展,2012,32(12):000.
[2]陈娟,周琼.朊蛋白在阿尔茨海默病视网膜退行性病变中的作用研究进展[J].眼科新进展,2015,35(1):081.[doi:10.13389/j.cnki.rao.2015.0023]
CHEN Juan,ZHOU Qiong.Recent advances in role of Prion protein in Alzheimer ’ s retinal degeneration disease[J].Recent Advances in Ophthalmology,2015,35(6):081.[doi:10.13389/j.cnki.rao.2015.0023]
[3]周琼,陈娟,徐婷婷. 细胞型朊蛋白在阿尔茨海默病和正常小鼠视网膜组织中的表达[J].眼科新进展,2015,35(7):601.[doi:10.13389/j.cnki.rao.2015.0163]
ZHOU Qiong,CHEN Juan,XU Ting-Ting. Expression of prion protein in retinal tissue of Alzheimer ’ s disease and normal mouse[J].Recent Advances in Ophthalmology,2015,35(6):601.[doi:10.13389/j.cnki.rao.2015.0163]
[4]董志章,李娟,孙雪荣,等.强光照致TgAPPswePS1转基因鼠视网膜功能障碍和结构损伤[J].眼科新进展,2017,37(4):317.[doi:10.13389/j.cnki.rao.2017.0080]
DONG Zhi-Zhang,LI Juan,SUN Xue-Rong,et al.Light exposure resulted in APPswe/PS1 transgenic mice retinal structural and functional disorder[J].Recent Advances in Ophthalmology,2017,37(6):317.[doi:10.13389/j.cnki.rao.2017.0080]
[5]李亭亭,刘芳,王方.年龄相关性黄斑变性与阿尔茨海默病的相关性[J].眼科新进展,2017,37(12):1189.[doi:10.13389/j.cnki.rao.2017.0300]
LI Ting-Ting,LIU Fang,WANG Fang.Research progress on the relationship between age-related macular degeneration and Alzheimer’s disease[J].Recent Advances in Ophthalmology,2017,37(6):1189.[doi:10.13389/j.cnki.rao.2017.0300]
[6]刘宇航,毛小雪,牛媖,等.青光眼发病机制相关分子途径研究进展[J].眼科新进展,2021,41(3):290.[doi:10.13389/j.cnki.rao.2021.0061]
LIU Yuhang,MAO Xiaoxue,NIU Ying,et al.Research progress on molecular pathways related to the pathogenesis of glaucoma[J].Recent Advances in Ophthalmology,2021,41(6):290.[doi:10.13389/j.cnki.rao.2021.0061]
[7]舒会叶,王怡欣,邵毅.超高分辨率OCT在眼科临床诊疗和基础研究中的应用[J].眼科新进展,2022,42(9):743.[doi:10.13389/j.cnki.rao.2022.0153]
SHU Huiye,WANG Yixin,SHAO Yi.Application of ultrahigh-resolution optical coherence tomography in clinical diagnosis and treatment and basic research of ophthalmic diseases[J].Recent Advances in Ophthalmology,2022,42(6):743.[doi:10.13389/j.cnki.rao.2022.0153]